INS and diabetes mellitus: Since the STZ model of diabetes induction causes the destruction of pancreatic β-cells, simulating the physiopathological process of the disease, it generates a deficiency in insulin biosynthesis and secretion and, consequently, an increase in serum glycemia content since it becomes unavailable to insulin-sensitive tissue.